Latest News about FBT
Recent news which mentions FBT
From ETF Trends
From MarketWatch
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
April 13, 2023
From Benzinga
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
April 13, 2023
From Benzinga
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
April 12, 2023
From Benzinga
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
April 11, 2023
From Benzinga
From Benzinga
US Judge Weighs Nationwide Ban On Abortion Pills
March 16, 2023
From Benzinga
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
March 01, 2023
From Benzinga
‘Just so full of autocracies’: For the Freedom 100 Emerging Markets ETF, outperformance in 2022 goes beyond nixing China
November 03, 2022
From MarketWatch
SBIO Rallied While Major Indexes Declined Last Week
October 04, 2022
From ETF Trends
First Trust’s Ryan Issakainen on Investment Opportunities and the Current Economic Environment
August 18, 2022
From ETF Trends
SBIO Rallies on M&A Announcements
August 10, 2022
From ETF Trends
SBIO Increases on Biotech’s Sustained Rebound
July 20, 2022
From ETF Trends
Energy ETFs are the unloved relative to ‘outstanding’ gains as growth bets in stock market head for worst first half ever
June 23, 2022
From MarketWatch
ETFs attract strong inflows in March, but not ‘all boats’ were lifted. Here’s where the money flowed—and where it didn’t.
April 07, 2022
From MarketWatch
Get Ready for a Biotech ETF Comeback
February 17, 2022
From ETF Trends
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.